Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 10 | 24 | 47 | 77 | 326 |
| Cost of Goods | N/A | 0 | 181 | 26 | 222 |
| Gross Profit | 10 | 24 | -134 | 51 | 104 |
| Operating Expenses | 3,196 | 2,435 | 2,805 | 3,579 | 2,909 |
| Operating Income | -3,187 | -2,411 | -2,758 | -3,502 | -2,583 |
| Interest Expense | 0 | 1 | 0 | 0 | 0 |
| Other Income | -2 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -3,188 | -2,412 | -2,758 | -3,502 | -2,584 |
| Net Income Continuous | -3,188 | -2,412 | -2,758 | -3,502 | -2,584 |
| Net Income | $-3,188 | $-2,412 | $-2,758 | $-3,502 | $-2,584 |
| EPS Basic Total Ops | -23.40 | -18.00 | -30.60 | -39.60 | -30.60 |
| EPS Basic Continuous Ops | -23.49 | -17.77 | -28.11 | -39.81 | -31.40 |
| EPS Diluted Total Ops | -23.40 | -18.00 | -30.60 | -39.60 | -30.60 |
| EPS Diluted Continuous Ops | -23.49 | -17.77 | -28.11 | -39.81 | -31.40 |
| EBITDA(a) | $-3,059 | $-2,286 | $-2,636 | $-3,378 | $-2,456 |